Yelena Yuriy Janjigian, MD, Memorial Sloan-Kettering gives an overview of her presentation, Molecular Subtyping/Profiling and Update in HER2 Targeted Therapy, which was discussed at the 2017 Great Debates and Updates in GI Malignancies in New York, NY.
Molecular Subtyping/Profiling and Update in HER2 Targeted Therapy
